Jungbrunnen Botox

A

Anzeige

Re: Jungbrunnen Botox
So ein Schwachsinn
 
hier muß ich sofort einhaken, denn da stand was von hyperhidrose, und daß man botox schon vor der jungbrunnensache bei übermäßigem schwitzen eingesetzt hat. wer weiß mehr darüber??
lg tina
 
Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase.

Karamfilov T, Konrad H, Karte K, Wollina U.

Department of Dermatology, Friedrich Schiller University of Jena, Germany.

BACKGROUND: Primary focal hyperhidrosis is a common condition that gives rise to functional and emotional problems and may disturb professional and social life. Recently, low-dose intracutaneous injections of botulinum toxin A have been shown to induce a temporary anhidrosis, with relapses occurring usually after 4 to 6 months. OBJECTIVE: To evaluate the short- and long-term effectiveness and possible adverse effects of high-dose botulinum toxin therapy in the treatment of axillary hyperhidrosis. DESIGN: In an open study, patients with focal hyperhidrosis were treated with intracutaneous injections of botulinum toxin A (Botox; Allergan Inc, Irvine, Calif). A total dose of 200 U of botulinum toxin A was used once per axilla. Patients were observed for up to 15 months. SETTINGS: University medical center. PATIENTS: Twenty-four patients with axillary hyperhidrosis were treated. Their ages ranged from 19 to 58 years (mean +/- SD, 34.8 +/- 12.4 years). MAIN OUTCOME MEASURES: Reduction of sweating as assessed by the Minor iodine-starch test and planimetry of hyperhidrotic areas. Patients were interviewed at the end of follow-up about their satisfaction with this treatment. RESULTS: Within 6 days, all patients reported cessation of excessive sweating. The mean +/- SD area of excessive sweating identified by the Minor iodine-starch test decreased from 19.27 +/- 11.95 cm2 to 0.25 +/- 0.61 cm2 (P<.001). The mean follow-up was 10.0 +/- 2.8 months (range, 5-15 months). Four patients (17%) reported a return of axillary hyperhidrosis after 7 to 10 months. All patients who experienced relapse showed an excellent response to a second treatment. The only adverse effects reported were temporary pain and burning during the injections. No muscular weakness, insensitivity, or systemic reactions were observed. CONCLUSIONS: High-dose botulinum toxin A seems to be as safe as low-dose botulinum toxin A in the treatment of axillary hyperhidrosis. The preliminary data suggest a lower rate of relapse.

und hier ein <a href="http://archderm.ama-assn.org/issues/v136n12/ffull/dlt1200-1.html" target ="_new"> Kommentar</a>.
Gruß,
Thomas
 
Botulinum? Ist das nicht der Bösewicht, der in den Konservendosen durch seine Gasbildung dafür sorgt, daß sie sich verbeulen? Der, von dem schon sehr sehr wenig tödlich ist? Und zwar blitzartig?

Danke, ich geh jetzt meine Falten streicheln!
 
Zurück
Oben